Company profile: Boreal Genomics
1.1 - Company Overview
Company description
- Provider of research tools and diagnostic tests based on monitoring tumor mutations from cell-free DNA in plasma.
Products and services
🔒
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Boreal Genomics
Bode Technology
HQ: United States
Website
- Description: Provider of forensic DNA analysis products and services for government agencies, serving the law enforcement and identification markets. Offers state-of-the-art human DNA analysis and innovative DNA collection products, with services including high-throughput DNA testing, casework analysis, and missing person identification.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Bode Technology company profile →
GeneCentric Therapeutics
HQ: United States
Website
- Description: Provider of molecular diagnostic tests and RNA-based informatics for oncology, including rT(I)ME Explorer for therapy-selective gene signatures, PurIST for PDAC subtyping, FGFR-PRS for identifying FGFR inhibitor candidates in urothelial cancer, AF-PRS for NSCLC chemotherapy prognosis, ICI-PRS for immune checkpoint inhibitor response prediction, and rADIO for antigen discovery and immunotherapy biomarkers.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full GeneCentric Therapeutics company profile →
Hain Lifescience
HQ: Germany
Website
- Description: Provider of in-vitro diagnostics as a manufacturer and distributor, located in Nehren.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Hain Lifescience company profile →
Locus Biosciences
HQ: United States
Website
- Description: Provider of CRISPR-engineered precision antibacterial therapies using bacteriophages. Portfolio includes LBP-EC01 for E. coli urinary tract infections; LBP-PA01 and LBP-SA01 targeting P. aeruginosa and S. aureus with Janssen; and LBP-KP01 for K. pneumoniae supported by CARB-X. Also offers robotic bacteriophage discovery and synthetic biology to engineer phage products.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Locus Biosciences company profile →
Vector BioMed
HQ: United States
Website
- Description: Provider of state-of-the-art custom vector design and GMP manufacturing, specializing in Lentiviral vector production for research, pre-clinical, IND-enabling, and clinical trials using a serum-free, chemically-defined process; algorithm-based vector design optimized for titer, transduction, and transgene expression; custom assay development; and support services for clinical development and commercialization.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Vector BioMed company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Boreal Genomics
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Boreal Genomics
2.2 - Growth funds investing in similar companies to Boreal Genomics
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Boreal Genomics
4.2 - Public trading comparable groups for Boreal Genomics
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →